We will rely on you to help lend your voice and support the biotechnology industry.
Bringing new treatments to patients, support public policies that promote innovation, improve patient access.
BIO International ConventionJune 3-6, 2019
BIO World Congress on Industrial Biotechnology and Ag TechJuly 8-11, 2019
BIO Industry Analysis Reports >>
Save. Advocate. Connect. Join Us.
A listing of all BIO members and subsidiaries.
February 11 - 12, 2019 | New York, New York
Mr. Andrews has spent most of his career as a C level executive leading operations, finance, commercial and clinical development for firms focused on new products that address inflammatory disease. His work has been primarily focused on skin disease, pneumonia, infant hypoxic ischemia and kidney failure. Mr. Andrews has been instrumental in translating research and academic discoveries into product development, clinical programs, building alliances and partnerships, and organizing operational teams. Mr. Andrews also led financing processes which have secured over $135M in equity funding for new ventures. Early in his career Mr. Andrews led the commercialization of several natural cell systems to prevent disease on fruits and vegetables and also launched several DNA diagnostic tests for periodontal disease. Mr. Andrews received graduate degrees in physical biochemistry (MS), and technology management (SM) from Purdue University, and the Massachusetts Institute of Technology
This speaker's sessions: